Immunocore's Grant

Immunocore raised a round of funding on November 05, 2012. Investors include Medical Research Council.

Immunocore is a biotechnology company, with a highly innovative immuno-oncology platform technology called ImmTACs. ImmTACs are a novel class of biologic drugs based on the Company's proprietary T cel…

Articles about Immunocore's Grant: